First Time Loading...
J

Jinyu Bio-Technology Co Ltd
SSE:600201

Watchlist Manager
Jinyu Bio-Technology Co Ltd
SSE:600201
Watchlist
Price: 9.14 CNY 2.24% Market Closed
Updated: May 2, 2024

Relative Value

The Relative Value of one Jinyu Bio-Technology Co Ltd stock under the Base Case scenario is 13.56 CNY. Compared to the current market price of 9.14 CNY, Jinyu Bio-Technology Co Ltd is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
13.56 CNY
Undervaluation 33%
Relative Value
Price
J
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
61
Median 3Y
7.1
Median 5Y
9.7
Industry
8.1
Forward
5.7
vs History
77
vs Industry
5
Median 3Y
41.4
Median 5Y
46
Industry
26.2
Forward
32.6
vs History
77
vs Industry
7
Median 3Y
26.6
Median 5Y
32.2
Industry
22.6
vs History
68
vs Industry
4
Median 3Y
50.4
Median 5Y
57.3
Industry
21.3
vs History
80
vs Industry
46
Median 3Y
2.2
Median 5Y
3.4
Industry
2.5
vs History
88
vs Industry
55
Median 3Y
6
Median 5Y
8.7
Industry
7.3
Forward
4.6
vs History
92
vs Industry
45
Median 3Y
10.3
Median 5Y
13.5
Industry
9.1
vs History
82
vs Industry
5
Median 3Y
34.9
Median 5Y
37
Industry
4.4
Forward
15.3
vs History
82
vs Industry
5
Median 3Y
34.9
Median 5Y
37
Industry
4.3
Forward
23.3
vs History
79
vs Industry
8
Median 3Y
23.3
Median 5Y
29.1
Industry
5.4
vs History
69
vs Industry
4
Median 3Y
44.4
Median 5Y
45.9
Industry
3.2
vs History
77
vs Industry
50
Median 3Y
2.2
Median 5Y
3.6
Industry
5

Multiples Across Competitors

Competitors Multiples
Jinyu Bio-Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jinyu Bio-Technology Co Ltd
SSE:600201
9.9B CNY 6.1 34.4 27.9 27.9
US
Abbvie Inc
NYSE:ABBV
285.6B USD 5.3 59.3 12.9 19.6
US
Amgen Inc
NASDAQ:AMGN
148.5B USD 5.3 22.1 16.4 24.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.6B USD 10.5 28.6 22.9 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.8B USD 7.5 25 16.6 18.2
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 168.6 6.8 8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.6B USD 6.2 -9 -9.5 -8.2
US
Biogen Inc
NASDAQ:BIIB
31.5B USD 3.3 27 13.8 17.3
KR
Celltrion Inc
KRX:068270
39.3T KRW 17.9 73.4 44.9 61.8

See Also

Discover More